Picture of BBS-Bioactive Bone Substitutes Oyj logo

BONEH BBS-Bioactive Bone Substitutes Oyj Cashflow Statement

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for BBS-Bioactive Bone Substitutes Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
FAS
FAS
FAS
FAS
FAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.64-2.73-2.77-3.09-3.48
Depreciation
Non-Cash Items0.1020.0860.20.1410.117
Other Non-Cash Items
Changes in Working Capital-0.1330.013-0.18-0.0890.227
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.44-2.42-2.52-2.82-2.92
Capital Expenditures-0.024-0.082-0.125-0.078
Purchase of Fixed Assets
Other Investing Cash Flow Items0000
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.024-0.082-0.125-0.0780
Financing Cash Flow Items0.0010.05
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2995.420.4433.173.38
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.172.92-2.20.2810.454